The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
PerspectivesFull Access

Mental Health Screening and Coordination of Care for Soldiers Deployed to Iraq and Afghanistan

Mental health screening of soldiers prior to deployment to a theater of war was first attempted by the U.S. Army in World War I in the hope of avoiding the high rates of psychiatric casualties observed in British and French troops, but it did not prevent extensive disability from shell shock in American World War I veterans (1). In World War II, the U.S. military carried out mass neuropsychiatric screening with the aim of identifying individuals who might be psychologically vulnerable to later psychiatric breakdown in the combat environment because of, for example, neuroses or minor personality defects (1). In World War II, as in later wars, predeployment screening to predict the development of future mental disorders was a failure for a variety of reasons, including imprecise screening methods and instruments, poor interrater reliability, high false positive rates, low thresholds for caseness that did not discern significant severity, and low predictive power (1).

A different form of predeployment mental health screening is that which screens for existing, rather than future, psychiatric disorders for purposes of psychiatric referral, surveillance, treatment, or discharge due to the severity or instability of the disorder (1). The U.S. military has gradually built mental health screening practices on this approach. In 1998, the U.S. Department of Defense introduced the 8-item self-report Pre-Deployment Health Assessment (PreDHA), which remains mandatory. A single question specifically addresses mental health: “During the past year, have you sought counseling or care for your mental health?” The form is reviewed with a primary care provider who determines whether referral is indicated (2). The PreDHA was unevaluated until 2007, when it was shown to have low validity, identifying less than half of the 4.2% of soldiers with a clinical record of psychiatric diagnosis within the year preceding their deployment to Afghanistan (2).

In 2006, concern that mentally unfit soldiers were being deployed to Iraq and Afghanistan led to a Congressional mandate for enhanced mental health screening. As a result, the Department of Defense issued a policy that specified criteria for deployment-limiting diagnoses (psychotic and bipolar disorders), medications (e.g., lithium), instability, and functional severity (3). The procedure by which health care providers conducting the screening were to operationalize the criteria was ill-defined, with practices varying across sites (4). U.S. military predeployment mental health screening has occurred on a large scale with minimal evaluation of its efficacy. Based on U.S. armed forces data (5), predeployment health assessments ranged from some 12,000 to 110,000 monthly since January 2003, averaging 34,774 per month in 2010.

The study by Warner et al. in this issue (6) makes two important contributions to our understanding of the effects and potential of predeployment mental health screening. First, it is the first study to evaluate the effectiveness of predeployment screening for psychiatric disorders for a modern military combat setting, and specifically for U.S. troops in Iraq. Second, the authors show how a clear protocol can systematically link predeployment screening with care coordination, integrated from predeployment to deployment settings, to reduce significant negative mental health outcomes in deployed soldiers. As implementation of the 2006 Department of Defense policy was uneven across brigades because of their rapid deployment during the 2007 surge of forces into Iraq, the authors took the opportunity to compare the effects of two forms of predeployment mental health assessment on dysfunctional outcomes during deployment: PreDHA assessment alone versus the PreDHA plus their predeployment mental health screen operationalizing the 2006 policy criteria (3) with coordinated care during deployment. Using a cohort design, the authors compared 10,678 soldiers from three brigades screened prior to deployment with 10,353 soldiers from three brigades that were not screened prior to deployment. The authors measured outcomes during deployment in Iraq that indicated significant dysfunction: seeking mental health services for combat stress, psychiatric disorders, or suicidal ideation; being placed on occupational duty restrictions (e.g., short-term weapons restrictions); and air evacuation from theater for behavioral health problems.

In the predeployment setting, the authors' screening protocol resulted in 7.7% of soldiers being referred for mental health evaluation-substantially more than the 0.3% referral rate from standard PreDHA screening of soldiers deployed to Afghanistan (2) and the 1.3% referral rate of U.S. Army soldiers screened in 2009 and 2010 with the PreDHA under 2006 Department of Defense guidelines (5). Mental health evaluation resulted in only 0.7% of screened soldiers not being cleared to deploy because of deployment-limiting diagnoses or medications. Among the screened soldiers, 7.0% were identified as having mental health needs and received a care plan for continuity of care while deployed in Iraq. Medication and monitoring during deployment were done predominantly by primary care providers with consultation and tracking by mental health specialists in a collaborative care model. Negative outcomes were significantly less frequent in the screened than in the unscreened brigades during 6 months of deployment.

One limitation of the study is that the authors relied on self-report to identify soldiers with psychiatric diagnoses or treatment. Stigma and barriers to mental health care in the military inhibit self-reporting and help-seeking (7) and very likely caused underdetection by the authors' screening. Second, the beneficial effects of identifying soldiers with psychiatric disorders at screening might dissipate beyond the study's 6-month span, given that rates of mental disorders in military populations increase with greater exposure to combat and with duration of deployment (7). Third, the study's outcome measures were not actual rates of mental disorders or symptoms in deployed troops. For example, the authors' reported rate of soldiers seeking care for suicidal ideation (0.4% of screened soldiers compared with 0.9% of unscreened soldiers) is based on a particular manifestation of suicidality and not the actual rate of suicidal ideation in troops (15.8% of surveyed soldiers in Iraq reported suicidal ideation within the previous 4 weeks in 2007 [7]). A fourth limitation of the study is its observational design. A randomized controlled trial would be ideal for future studies of screening efficacy. Strengths of the study are its 100% response rate, the standardized tracking system to monitor outcomes, and the large sample size, which allows evaluation of important but uncommon outcomes (e.g., air evacuation).

It is important to keep in mind that this study does not show that more detailed mental health screening itself improves outcomes. The screening was not tested on its own but was linked to proactive, improved coordination of care in the deployed setting. U.S. soldiers with mental health problems in Iraq and Afghanistan report significant stigma and barriers to care, particularly soldiers in forward combat zones (7, 8). Warner and colleagues' study implies the possibility that stigma, barriers to care, and relapse may be lessened and symptoms and medication continuity improved if soldiers with mental disorders enter their deployment already linked to treatment with a care provider.

Recent changes in U.S. military policies and programs are promising for integrated mental health screening and care. A 2010 Department of Defense policy expands mental health screening and surveillance (9). Collaborative mental health care is the basis of the RESPECT-Mil program for depression and posttraumatic stress disorder (10) and the forthcoming Comprehensive Behavioral Health System of Care (11). It is incumbent on the U.S. military to prospectively evaluate these new programs in order to provide high-quality evidence-based systems for supporting soldiers in the field, as well as for soldiers who have returned to their base or home.

Address correspondence and reprint requests to Dr. Hicks,
Health Service and Population Research Department, Institute of Psychiatry, King's College London, De Crespigny Park, London, SE5 8AF, UK
; (e-mail).

Editorial accepted for publication January 2011.

Dr. Hicks reports no financial relationships with commercial interests.

References

1. Jones E , Hyams KC , Wessely S: Screening for vulnerability to psychological disorders in the military: an historical study. J Med Screen 2003; 10:40–46Crossref, MedlineGoogle Scholar

2. Nevin RL: Low validity of self-report in identifying recent mental health diagnosis among US service members completing Pre-Deployment Health Assessment (PreDHA) and deployed to Afghanistan, 2007: a retrospective cohort study. BMC Public Health 2009; 9:376Crossref, MedlineGoogle Scholar

3. Assistant Secretary of Defense: Policy Guidance for Deployment-Limiting Psychiatric Conditions and Medications. Washington, DC, Department of the Army, 2006Google Scholar

4. US Government Accountability Office: DoD Health Care: Mental Health and Traumatic Brain Injury Screening Efforts Implemented, But Consistent Pre-Deployment Medical Record Review Policies Needed (report no GAO-08-615). Washington, DC, US Government Accountability Office, 2008Google Scholar

5. Armed Forces Health Surveillance Center: Update: Deployment Health Assessments, US Armed Forces, November 2010. Medical Surveillance Monthly Report (MSMR) 2010; 17 (11): 22–23Google Scholar

6. Warner CH , Appenzeller GN , Parker JR , Warner CM , Hoge CW: Effectiveness of mental health screening and coordination of in-theater care prior to deployment to Iraq: a cohort study. Am J Psychiatry 2011; 168:378–385LinkGoogle Scholar

7. Mental Health Advisory Team VI: Operation Iraqi Freedom 07–09. Office of the Surgeon, Multi-National Corps–Iraq, and Office of the Surgeon General, United States Army Medical Command, May 8, 2009. www.armymedicine.army.mil/reports/mhat/mhat_vi/MHAT_VI-OIF_Redacted.pdfGoogle Scholar

8. Bryan CJ , Kanzler KE , Durham TL , West CL , Greene E: Challenges and considerations for managing suicide risk in combat zones. Mil Med 2010; 175:713–718Crossref, MedlineGoogle Scholar

9. Assistant Secretary of Defense: Mental Health Assessments for Members of the Armed Forces Deployed in Connection With a Contingency Operation. Washington, DC, Department of the Army, 2010Google Scholar

10. Engel CC , Oxman T , Yamamoto C , Gould D , Barry S , Stewart P , Kroenke K , Williams JW , Dietrich AJ: RESPECT-Mil: feasibility of a systems-level collaborative care approach to depression and post-traumatic stress disorder in military primary care. Mil Med 2008; 173:935–940Crossref, MedlineGoogle Scholar

11. McKaughan J: Q&A: Lieutenant General Eric B. Schoomaker: Soldier Physician: Comprehensive Health Care Protection for Every Soldier, Everywhere. Military Medical/CBRN Technology 2010; 14(7). www.military-medical-technology.com/mmt-home/279-mmt-2010-volume-14-issue-7-Oct/3466-qaa-lieutenant-general-eric-b-schoomaker.htmlGoogle Scholar